Detailed Information on Publication Record
2021
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI
SELINGEROVÁ, Iveta, Dalibor VALÍK, Lenka GESCHEIDTOVÁ, Vladimír ŠRÁMEK, Z. CERMAKOVA et. al.Basic information
Original name
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI
Authors
SELINGEROVÁ, Iveta, Dalibor VALÍK, Lenka GESCHEIDTOVÁ, Vladimír ŠRÁMEK, Z. CERMAKOVA and Lenka ZDRAŽILOVÁ DUBSKÁ
Edition
Journal of Medical Virology, Hoboken, Wiley, 2021, 0146-6615
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30230 Other clinical medicine subjects
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 20.693
Organization unit
Faculty of Medicine
UT WoS
000583206600001
Keywords (in Czech)
anti‐ SARS‐ CoV‐ 2 IgG; anti‐ SARS‐ CoV‐ 2 IgM; CLIA; inter‐ assay batch variation; interpretative inconsistency
Keywords in English
anti‐ SARS‐ CoV‐ 2 IgG; anti‐ SARS‐ CoV‐ 2 IgM; CLIA; inter‐ assay batch variation; interpretative inconsistency
Změněno: 8/2/2022 10:35, Mgr. Tereza Miškechová
Abstract
V originále
Plasma specimens from coronavirus disease 2019 patients were double-tested for anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies by two different batches of MAGLUMI 2019-nCov immunoglobulin M/immunoglobulin G (IgM/IgG) assays to evaluate IgM/IgG levels, qualitative interpretation, antibody kinetics, and linearity of diluted specimen. Here we show that (i) high-level IgM specimens need to be diluted with negative human plasma but not kit diluents and (ii) measured anti-SARS-CoV-2 IgM/IgG concentrations are substantially higher with later marketed immunoassay batch leading to (iii) the change of qualitative interpretation (positive vs. negative) in 12.3% of specimens measured for IgM, (iv) the informative time-course pattern of antibody production only when data from different immunoassay batches are not combined.
Links
90128, large research infrastructures |
|